R-Linezolid
|
R利奈唑胺
|
872992-20-6
|
Dabigatran iMpurity F
|
达比加群杂质F
|
1642853-67-5
|
4-methyl-N-(4-nitrophenyl)-1-Piperazineacetamide
|
尼达尼布杂质43
|
708279-23-6
|
INDEX NAME NOT YET ASSIGNED
|
达比加群酯杂质
|
2518152-88-8
|
|
达比加群酯杂质
|
3052343-45-7
|
Nidanib Impurity 7
|
尼达尼布杂质7
|
262368-25-2
|
2-OXO-2,3-DIHYDRO-1H-INDOLE-6-CARBOXYLIC ACID ETHYL ESTER
|
2-吲哚酮-6-甲酸乙酯
|
954239-49-7
|
N-methyl-2-(4-methylpiperazin-1-yl)-N-(4-nitrophenyl)acetamide
|
尼达尼布杂质12
|
1139453-98-7
|
Dabigatran iMpurity O
|
达比加群杂质O
|
948551-71-1
|
Dabigatran Impurity 29
|
达比加群酯杂质29
|
1610758-21-8
|
Desacetyl-N,O-descarbonyl Linezolid
|
利奈唑胺杂质 10
|
333753-72-3
|
(Z)-methyl 3-(((4-(methylamino)phenyl)amino)(phenyl)methylene)-2-oxoindoline-6-carboxylate
|
尼达尼布杂质D
|
1987887-92-2
|
Dabigatran Impurity 38
|
达比加群杂质38
|
1416446-40-6
|
β-Alanine, N-[[2-[[[4-(aminoiminomethyl)phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl-, methyl ester
|
达比加群甲酯杂质
|
771459-37-1
|
(Z)-methyl 3-(hydroxy(phenyl)methylene)-2-oxoindoline-6-carboxylate
|
尼达尼布杂质8
|
2093243-16-2
|
|
尼达尼布杂质
|
2102162-79-6
|
Nintedanib Impurity 107
|
尼达尼布杂质40
|
78466-25-8
|
N-[(4-tert.butoxycarbonyl-piperazin-1-yl)-methylcarbonyl]-N-methyl-p-phenylenediamine
|
尼达尼布杂质
|
652140-02-8
|
N-Acetyl Nintedanib
|
尼达尼布杂质163
|
2380229-45-6
|
|
尼达尼布杂质
|
2514952-69-1
|
Dabigatran Etexilate Impurity O HCl
|
达比加群酯杂质O盐酸盐
|
211914-50-0
|
BIBF 1202
|
尼达尼布杂质BIBF 1202
|
894783-71-2
|
Dabigatran iMpurity K
|
达比加群杂质K
|
1580491-16-2
|
Nintedanib
|
(3E)-1-(2-氯乙酰基)-2,3-二氢-3-(甲氧基苯基亚甲基)-2-氧代-1H-吲哚-6-羧酸甲酯
|
1174335-83-1
|
Dabigatran Impurity 18
|
达比加群杂质 18
|
1422435-35-5
|
Dabigatran etexilate C5
|
达比加群酯杂质C5
|
1416446-45-1
|
|
尼达尼布杂质
|
2519816-53-4
|
Linezolid N-Oxide
|
利奈唑胺-N-氧化物
|
189038-36-6
|
Dabigatran Etexilate Impurity X
|
达比加群酯杂质X
|
1643377-48-3
|
Dabigatran Impurity 9
|
达比加群酯杂质9
|
1408238-41-4
|
Nintedanib impurity I
|
尼达尼布杂质I
|
334951-61-0
|
(Z)-3-(hydroxy(phenyl)methylene)-2-oxoindoline-6-carboxylic acid compound with 3-benzoyl-2-oxoindoline-6-carboxylic acid
|
尼达尼布杂质17
|
1253768-91-0
|
3-Amino-4-(carboxymethyl)benzoic acid
|
3-氨基-4-(羧甲基)苯甲酸
|
1373232-85-9
|
Nintedanib Impurity 52
|
尼达尼布杂质52
|
2410284-89-6
|
Acetamide, 2,2,2-trichloro-N-methyl-N-(4-nitrophenyl)-
|
尼达尼布杂质
|
126434-07-9
|
1-Piperazinecarboxylic acid, 4-[2-[methyl(4-nitrophenyl)amino]-2-oxoethyl]-, 1,1-dimethylethyl ester
|
尼达尼布杂质
|
1277571-69-3
|
β-Alanine, N-[[2-[[[4-[(E)-amino[[[(4-methylpentyl)oxy]carbonyl]imino]methyl]phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl-, ethyl ester
|
达比加群酯杂质
|
1873316-88-1
|
|
利奈唑胺杂质
|
3054252-47-7
|
Bis-Linezolid
|
利奈唑胺二聚物
|
908143-04-4
|
Dabigatran iMpurity D
|
达比加群杂质D
|
1610758-22-9
|
Des-(N-2-pyridyl-β-alanine Ethyl Ester) Dabigatran Etexilate 5-Ethyl Carboxylate
|
达比加群酯杂质G
|
2768270-28-4
|
Lifitegrast Impurity 30
|
立他司特杂质30
|
1194864-18-0
|
(S)-N-(3-Chloro-2-hydroxypropyl)acetamide
|
利奈唑胺杂质19
|
224323-47-1
|
Dabigatran Impurity 10 (DABRC-10)
|
达比加群杂质10(DABRC-10)
|
1304574-20-6
|
N-(4-Nitrophenyl)-2,2,2-trichloroacetamide
|
尼达尼布杂质
|
4306-32-5
|
Desethyl Dabigatran Etexilate
|
去乙基达比加群酯
|
212321-78-3
|
(E)-Methyl 1-acetyl-3-(Methoxy(phenyl)Methylene)-2-oxoindoline-6-carboxylate
|
(E)- 1-乙酰基-3-(甲氧基(苯基)亚甲基)-2-氧代吲哚-6-羧酸酯甲酯
|
1168152-07-5
|
Dabigatran iMpurity L
|
达比加群杂质L
|
1422435-41-3
|
Dabigatran etexilate Imp.C
|
达比加群酯杂质C
|
1408238-40-3
|
4-Amino-N-methylaniline
|
N-甲基对苯二胺
|
5395-70-0
|
2-OXO-2,3-DIHYDRO-1H-INDOLE-6-CARBOXYLIC ACID
|
2-氧代吲哚啉-6-羧酸
|
334952-09-9
|
Dabigatran Etexilate iMpurity C4
|
邻丁基达比加群乙酯
|
1416446-43-9
|
N1-(4-NITROPHENYL)-2-CHLOROACETAMIDE
|
2-氯-N-(4-硝基苯基)乙酰胺
|
17329-87-2
|
Lifitegrast Impurity 29
|
立他司特杂质29
|
2762168-17-0
|
1H-Indole-6-carboxylic acid, 3-[[[4-[(2-chloroacetyl)methylamino]phenyl]amino]phenylmethylene]-2,3-dihydro-2-oxo-, methyl ester, (3Z)-
|
尼达尼布杂质
|
1987887-93-3
|
Dabigatran etexilate
|
达比加群酯API
|
211915-06-9
|
Dabigatran Etexilate iMpurity H
|
达比加群酯杂质H
|
1702936-92-2
|
N-(4-aMinophenyl)-2-chloro-N-MethylacetaMide
|
尼达尼布杂质
|
855860-75-2
|
Dabigatran Impurity 10
|
达比加群脂杂质10
|
1422435-37-7
|
(S)-5-((Tert-butylamino)methyl)-3-(3-fluoro-4-morpholinophenyl)oxazolidin-2-one
|
利奈唑胺杂质11
|
1215006-08-8
|
Linezolid Impurity 12
|
利奈唑胺杂质12
|
1215006-11-3
|
Nintedanib Impurity 59
|
尼达尼布杂质59
|
70380-66-4
|
Dabigatran Impurity
|
达比加群酯杂质
|
1807758-61-7
|
1H-Indole-6-carboxylic acid, 2,3-dihydro-3-[[[4-[methyl[2-(4-methyl-1-piperazinyl)acetyl]amino]phenyl]amino]phenylmethylene]-2-oxo-, ethyl ester
|
尼达尼布杂质
|
2295911-98-5
|
2-CHLORO-N-METHYL-N-(4-NITROPHENYL)ACETAMIDE
|
2-氯-N-甲基-N-(4-硝基苯基)乙酰胺
|
2653-16-9
|
|
利奈唑胺杂质
|
3054252-48-8
|
Nintedanib
|
尼达尼布
|
656247-17-5
|
N-[[(5S)-3-[4-(4-Morpholinyl)phenyl]-2-oxo-5-oxazolidinyl]Methyl]acetaMide
|
利奈唑胺脱氟杂质
|
556801-15-1
|
N-[(2R)-3-[[3-Fluoro-4-(4-morpholinyl)phenyl]amino]-2-hydroxypropyl]acetamide
|
N-[(2R)-3-[[3-氟-4-(4-吗啉基)苯基]氨基]-2-羟丙基]乙酰胺
|
333753-67-6
|
Dabigatran Etexilate iMpurity O
|
达比加群酯杂质O
|
1349500-09-9
|
Dabigatran iMpurity E
|
达比加群杂质E
|
1456889-80-7
|
Dabigatran Impurity p
|
达比加群酯杂质F
|
1408238-37-8
|
Nintedanib impurity G
|
尼达尼布杂质G
|
894783-61-0
|
Dabigatran Impurity 24
|
达比加群酯杂质24
|
2243727-83-3
|
Nintedanib impurity 03
|
尼达尼布杂质03
|
2410284-90-9
|
Nintedanib Impurity 35
|
尼达尼布杂质35
|
1895918-24-7
|
Acetamide, 2-chloro-N-methyl-N-(2-nitrophenyl)-
|
尼达尼布杂质2
|
2653-15-8
|
Acetamide, 2-hydroxy-N-methyl-N-(4-nitrophenyl)-
|
尼达尼布杂质
|
1860012-61-8
|
Nintedanib Impurity 57
|
尼达尼布杂质57
|
130652-10-7
|
Nintedanib Impurity 30
|
尼达尼布杂质30
|
1038972-16-5
|
|
尼达尼布杂质
|
676326-36-6
|
(S)-5-(Aminomethyl)-3-(3-fluoro-4-morpholinophenyl)oxazolidin-2-one
|
(S)-5-(氨基甲基)-3-(3-氟-4-吗啉基苯基)-2-唑烷酮(利奈唑胺碱中间体)
|
168828-90-8
|
Linezolid Related Compound B
|
利奈唑胺杂质B
|
216868-57-4
|
Nintedanib impurity E
|
尼达尼布杂质E
|
262366-32-5
|
N-ACETYLOXINDOLE 97
|
N-乙酰基吲哚酮
|
21905-78-2
|
|
利奈唑胺杂质
|
2842071-59-2
|
1-Piperazineacetamide, N-(4-aminophenyl)-N-methyl-
|
N-(4-氨基苯基)-N-甲基-2-(哌嗪-1-基)乙酰胺
|
2243384-71-4
|
Dabigatran Etexilate Impurity 64
|
达比加群酯杂质64
|
355809-32-4
|
INDEX NAME NOT YET ASSIGNED
|
2,2'-(哌嗪-1,4-二基)双(N-甲基-N-(4-硝基苯基)乙酰胺)
|
2410649-54-4
|
(5S,5'S)-5,5'-(azanediylbis(methylene))bis(3-(3-fluoro-4-morpholinophenyl)oxazolidin-2-one)
|
利奈唑胺杂质15
|
2307625-63-2
|
1H-Benzimidazole-5-carboxylic acid, 2-[[(4-cyanophenyl)amino]methyl]-1-methyl-, methyl ester
|
达比加群酯杂质
|
1970195-83-5
|
Linezolid Impurity (N,O-Desethylene Linezolid)
|
利奈唑胺杂质(N,O-去乙烯利奈唑胺)
|
1219708-30-1
|
Dabigatran Etexilate iMpurity I
|
达比加群乙二酸杂质I
|
255706-13-9
|
Dabigatran Etexilate Impurity H
|
达比加群酯杂质H
|
211915-00-3
|
Dabigatran Etexilate iMpurity 1
|
达比加群酯杂质1
|
1610758-19-4
|
Dabigatran etexilate Impurity R
|
达比加群乙二酸杂质R
|
1610758-20-7
|
Dabigatran Impurity 16
|
达比加群杂质10
|
211916-39-1
|
Dabigatran Impurity 5
|
达比加群酯杂质5
|
2225986-95-6
|
Dabigatran Impurity 19
|
达比加群杂质 19
|
2225986-94-5
|
Glycine, N-methyl-N-(4-nitrophenyl)-
|
尼达尼布杂质45
|
98953-48-1
|